Comparing Lexaria Bioscience (OTCMKTS:LXRP) and Blue Gold (NASDAQ:BGL)

Lexaria Bioscience (OTCMKTS:LXRP) and Blue Gold (NASDAQ:BGL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, risk, earnings, analyst recommendations and profitability.

Profitability

This table compares Lexaria Bioscience and Blue Gold’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lexaria Bioscience	-1,046.77%	-157.62%	-148.09%
Blue Gold	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Lexaria Bioscience and Blue Gold, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lexaria Bioscience	0	0	0	0	0.00
Blue Gold	1	0	0	0	1.00

Given Lexaria Bioscience’s higher probable upside, research analysts clearly believe Lexaria Bioscience is more favorable than Blue Gold.

Institutional and Insider Ownership

0.1% of Lexaria Bioscience shares are owned by institutional investors. Comparatively, 24.6% of Blue Gold shares are owned by institutional investors. 19.9% of Blue Gold shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Lexaria Bioscience and Blue Gold”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lexaria Bioscience	$380,000.00	0.00	-$4.09 million	N/A	N/A
Blue Gold	N/A	N/A	$700,000.00	N/A	N/A

Blue Gold has lower revenue, but higher earnings than Lexaria Bioscience.

Summary

Blue Gold beats Lexaria Bioscience on 7 of the 9 factors compared between the two stocks.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

About Blue Gold

Blue Gold Limited is a gold mining company developing a portfolio of assets anchored by the historic Bogoso Prestea Mine in the Ashanti region of Ghana. Blue Gold Limited, formerly known as Perception Capital Corp. IV, is based in NEW YORK.